Resource Library

Adopting ePRO in early-phase trials can revolutionize data collection, reduce participant burden and increase the accuracy of results. Not only does this improve patient care, but it also provides commercial advantages to sponsors.

Emerging medical device company NeuraLace doubles clinical trial enrollment and demonstrates improved participant compliance with Medrio’s EDC and ePRO offerings.

Medrio’s electronic data capture (EDC) offers the speed, support, security, and ease of use necessary in the race to uncover biotech breakthroughs to improve the lives of people with diabetes.

Global medical device maker Nevro successfully integrates Medrio EDC and ePRO to transition from paper to digital data collection.

The use of multimedia, including videos, animations, or interactive graphics in clinical trials is growing. Although its impact on the success of clinical trials is not yet fully understood, studies have shown that it can improve participant engagement, comprehension, and retention of study information.

RefleXion taps Medrio’s service and expertise to help build and launch the first studies for the breakthrough cancer treatment SCINTIX™ biology-guided radiotherapy.